Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Elicera Therapeutics AB

Closing information (x1000 EUR)

Closing information 2023/12 2022/12 2021/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 7 More Arrow 12 Less Arrow 0
Earnings before taxes -1,478 Less Arrow -1,747 More Arrow -276
EBITDA -1,540 Less Arrow -1,739 More Arrow -275
Total assets 2,720 More Arrow 4,161 More Arrow 5,352
Current assets 2,719 More Arrow 4,116 More Arrow 5,302
Current liabilities 1,242 Less Arrow 1,214 Less Arrow 244
Equity capital 1,478 More Arrow 2,947 More Arrow 5,108
- share capital 75 Equal arrow 75 More Arrow 81
Employees (average) 2 Equal arrow 2 Less Arrow 1

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 54.3% More Arrow 70.8% More Arrow 95.4%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -54.1% More Arrow -41.7% More Arrow -5.2%
Current ratio 218.9% More Arrow 339.0% More Arrow 2173.0%
Return on equity (ROE) -100% More Arrow -59.3% More Arrow -5.4%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 More Arrow 1 Less Arrow 0
Chg. No. of employees % 0% More Arrow 100% Less Arrow 0%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.